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ABSTRACT: Polymer-stabilized complex coacervate microdroplets have emerged as a
robust platform for synthetic cell research. Their unique core−shell properties enable the
sequestration of high concentrations of biologically relevant macromolecules and their
subsequent release through the semipermeable membrane. These unique properties render
the synthetic cell platform highly suitable for a range of biomedical applications, as long as
its biocompatibility upon interaction with biological cells is ensured. The purpose of this
study is to investigate how the structure and formulation of these coacervate-based
synthetic cells impact the viability of several different cell lines. Through careful
examination of the individual synthetic cell components, it became evident that the
presence of free polycation and membrane-forming polymer had to be prevented to ensure
cell viability. After closely examining the structure−toxicity relationship, a set of conditions
could be found whereby no detrimental effects were observed, when the artificial cells were
cocultured with RAW264.7 cells. This opens up a range of possibilities to use this modular
system for biomedical applications and creates design rules for the next generation of coacervate-based, biomedically relevant
particles.
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■ INTRODUCTION
Complex coacervates have recently gained significant interest
in the fields of cell biology,1−3 synthetic cell engineering,4−7
and biomedical applications.8,9 They are liquid−liquid phase-
separated compartments formed by synthetic or biological
polyelectrolytes (e.g., polyacrylamides, polypeptides, and
DNA). Their formation is driven by both an increase in
entropy as a result of the release of counterions in solution and
a decrease in enthalpy as a result of electrostatic
interactions.10,11 Complex coacervates are believed to have
played an important role in the origin of life.12 This has
inspired scientists to utilize the self-assembling and crowded
nature of coacervates to engineer synthetic cells4 and artificial
organelles,13−15 which are capable of mimicking specific
biological features including compartmentalization and com-
munication.5,16 A highly interesting characteristic of complex
coacervates is their ability to host a great variety of so-called
client molecules.17 This characteristic has been exploited to
encapsulate proteins and small molecules inside the coacervate
phase to study biological processes in a simple and highly
controlled environment.17−21
The ability to sequester high amounts of biologically
relevant macromolecules is also important for the application
of coacervate-based synthetic cells in the biomedical field. In
fact, encapsulation of cargo in complex coacervates has already
been demonstrated across a range of biomedical disciplines,
including the development of sensors, biomimetic adhesives,
and delivery platforms.9 Encapsulation can be achieved by
using the cargo as part of the coacervate matrix,22 as a result of
specific interactions,18 or by preferential partitioning.23−27
These methods result in the significant enrichment and
protection of cargo inside the aqueous environment but also
allow for their controlled release upon dissociation of the
coacervate phase or as a reaction to external triggers. Overall,
the development of programmable complex coacervate−
synthetic cells shows great potential for creating novel delivery
strategies, provided they are compatible with living cells.
Biocompatibility is thus a crucial design feature for
coacervate formulations for in vitro and in vivo use and is
closely linked to the choice of polymer that makes up the
complex coacervate core. The relatively straightforward process
of mixing oppositely charged polyelectrolytes has given rise to
a broad range of materials that are being utilized for complex
coacervation. These materials include polyanions (e.g., RNA,28
ATP,13 hyaluronic acid,29 and heparin26) and polycations (e.g.,
diethylaminoethyl (DEAE) dextran,30 poly(ethylene argininy-
laspartate diglyceride) (PEAD),26 and poly-L-lysine
(PLL)13,31). However, not all of these materials are
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appropriate for cocultivation with biological cells, mostly due
to their high charge.32 Previous studies have reported the
preparation of biocompatible coacervates through the use of
natural polymers27,33,34 or via careful design of synthetic
polymers.26,35,36 A disadvantage of most complex coacervates,
however, is their inherent lack of long-term (>24 h) stability.
In other words, there is little control over the coalescence of
these droplets or their deposition on surfaces, which limits
their use for long-term interactions with living cells.
In previous work, we reported on coacervate-based synthetic
cells with a stabilizing block copolymer, which circumvents
these processes.37 More specifically, 12−16 kDa amylose
chains were modified with a quaternary amine (Q) or a
carboxymethyl (CM) group, introducing either a positive or
negative charge on the amylose, respectively. Upon mixing,
these charged polymers phase-separated into liquid coacervate
droplets (Figure 1A). To terminate the growth of the droplets,
a stabilizing synthetic block terpolymer was added that self-
assembles around the droplet periphery. This biodegradable
terpolymer, PEG−PCL-g-TMC−PGlu, comprises a poly-
(ethylene glycol) (PEG) chain that prevents internalization
in the coacervate phase, a hydrophobic poly((ε-caprolactone)-
gradient-trimethylene carbonate) (PCL-g-TMC) block that
arranges the terpolymer around the droplet, and a negatively
charged poly(glutamic acid) (pGlu) domain that interacts with
the droplet periphery via electrostatic interactions.
The hierachical assembly of these synthetic cells allows for
tuning of the properties of all of the different components,
which enables control over the molecular interactions that
dictate cargo sequstration and release.18,23 However, the
multicomponent assembly process induces a level of complex-
ity that makes it more difficult to pinpoint biocompatibility
issues. Progression of these coacervate-based synthetic cells in
the field of biomedical applications can only be achieved when
there is a clear understanding of their toxicity when in contact
with living cells. The purpose of this study is to investigate how
the structure and formulation of these coacervate-based
synthetic cells impacts cell viability. Examination of the
individual synthetic cell components revealed that the origin
of initial synthetic cell toxicity could be attributed to the toxic
character of free polycation and terpolymer. Careful examina-
tion of the structure−toxicity relationship disclosed a set of
conditions whereby no detrimental effects were observed when
cocultured with RAW264.7 cells. This study advances the
development of synthetic cells for applications in a range of
biomedical disciplines and outlines the criteria for the next
generation of coacervate-based, biomedically relevant particle
designs.
■ MATERIALS AND METHODS
Materials. All chemicals were used as received unless otherwise
stated. For the synthesis of the terpolymer, monomethoxy poly-
(ethylene glycol) 2 kDa was purchased from Rapp Polymere,
trimethylene carbonate was purchased from TCI Europe, and dry
methanesulfonic acid was kindly supplied by Arkema. For the
preparation of modified amylose derivatives, amylose (12−16 kDa)
was supplied by Carbosynth and 3-chloro-2-hydroxypropyltrimethy-
lammonium chloride (65 wt % in water) was supplied by TCI Europe.
For cell culture, Dulbecco’s modified Eagle’s medium (DMEM) (no.
41965062), fetal bovine serum (FBS) (no. 26140079), penicillin/
streptomycin (no. 15140122), and trypsin-EDTA (0.05%) (no.
25300054) were purchased from Fisher Scientific. Vascular cell
basal medium (VCBM) (no. 100-030) and Endothelial Cell Growth
Kit-VEGF (no. 100-041) were purchased from LGC standards. Pacific
Blue Annexin V Apoptosis Detection Kit with 7-AAD (no. 640926)
was purchased from BioLegend. LysoTracker Green DND-26 (no.
H3570), Hoechst 33342 (no. H3570), and Live Cell Imaging
Solution (no. A14291DJ) were purchased from ThermoFisher
Scientific. (All other chemicals were supplied by Sigma-Aldrich.)
Figure 1. Self-assembly of stabilized coacervate-based synthetic cells.
(A) Schematic illustrating the coacervation of the oppositely charged
polycation (12−16 kDa) quaternary amylose (Q-am) and polyanion
(12−16 kDa) carboxymethyl amylose (CM-am) followed by self-
assembly of terpolymer poly(ethylene glycol)−poly(caprolactone-
gradient-trimethylene carbonate)−poly(glutamic acid) (PEG−PCL-g-
TMC−PGlu) on the droplet interface. (B) Confocal microscopy
image of synthetic cells formed in cell culture medium. The
terpolymer is visualized with Nile Red. Scale bar represents 50 μm.
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Synthesis of Modified Amyloses. Both quaternized (Q-
amylose) and carboxymethylated (CM-amylose) amyloses were
prepared in accordance with previously published procedures.37 In
short, amylose was dissolved in a solution of aqueous NaOH prior to
addition of either 3-chloro-2-hydroxypropyltrimethylammonium
chloride solution (for Q-amylose) or chloroacetic acid (for CM-
amylose). After the reaction, the reaction mixture was neutralized with
acetic acid, precipitated into cold ethanol, and dialyzed extensively
against Milli-Q before being lyophilized to yield CM-amylose (90%
yield) or Q-amylose (80% yield) as fluffy white solids. The degrees of
substitution were determined by 1H NMR spectroscopy (Figure S1).
Synthesis of Cy5-Labeled Q-Amylose. First, amylose was
modified in accordance with a previously published procedure to
introduce an azido functional group at the reducing end.38 Amylose
(100 mg, 7.14 μmol, 1 equiv) was dissolved in 2.1 mL of deionized
water containing N,N-diisopropylethylamine (93.3 μL, 536 μmol, 75
equiv) by heating to 95 °C in an oil bath. Once dissolved, the solution
was cooled to room temperature and sodium azide (116 mg, 1.79
mmol, 250 equiv) was added, followed by 2-chloro-1,3-dimethylimi-
dazolinium chloride (30.2 mg, 179 μmol, 25 equiv). The reaction
mixture was left to stir at room temperature overnight. The product
was purified via precipitation into cold ethanol, followed by extensive
dialysis against Milli-Q before being lyophilized to yield azido amylose
(91 mg, 91% yield) as a fluffy white solid. The introduction of the
azide functionality at the reducing end was confirmed by the
appearance of a new peak at 4.8 ppm by 1H NMR spectroscopy. Prior
to the conjugation of DBCO-Cy5, azido amylose was subjected to the
same cationization protocol (described earlier) to yield azido-Q-
amylose. For the labeling reaction, azido-Q-amylose (12 mg, 0.86
μmol, 10 equiv) was dissolved in 40 μL of Milli-Q, to which was
added 10.3 μL of a dimethylformamide (DMF) solution of DBCO-
Cy5 (10 mg/mL, 0.086 μmol, 1 equiv). The reaction was left to react
overnight at room temperature, prior to precipitation in cold ethanol
and lyophilization to yield a fluffy blue solid (25% yield, as
determined by UV−vis spectroscopy).
Synthesis of Terpolymer. PEG−PCL-g-TMC−PGlu was pre-
pared in accordance with previously published procedures.37 In short,
poly(ethylene glycol) monomethyl ether was used to initiate the ring-
opening polymerization of ε-caprolactone and trimethylene carbo-
nate. The terminal alcohol of this polymer was subsequently modified
via a Steglich esterification with Boc-L-Phe-OH to yield a primary
amine after trifluoroacetic acid (TFA) deprotection. The final poly(L-
glutamic acid) block was introduced by the ring-opening polymer-
ization of N-carboxyanhydride γ-benzyl L-glutamate, followed by
hydrogenation. At each step, the polymer modifications were
confirmed by both GPC and 1H NMR (Figures S11 and S12).
Synthesis of Dy650-Labeled Terpolymer. PEG−PCL-g-
TMC−PGlu−NH2 (10 mg, 0.77 μmol, 10 equiv) was dissolved in
10 μL of DMF, to which was added 8.2 μL of a DMF solution of
DyLight650-NHS ester (10 mg/mL, 0.08 μmol, 1 equiv). The
reaction was left to react overnight at room temperature prior to
precipitation in cold methanol (twice) and lyophilization from
dioxane to yield a gummy blue solid (54% yield, as determined by
UV−vis spectroscopy). The unlabeled terpolymer was not separated
from the Dy650 terpolymer, as it was diluted further with terpolymer
for the cell experiments anyway.
Preparation of Coacervates. Q-amylose with degrees of
substitution (DS) of 1 and 0.5 and CM-amylose with a DS of 0.4
were dissolved separately in cell culture medium (DMEM,
supplemented with 10% (v/v) FBS and 1% (v/v) penicillin/
streptomycin or VCBM, supplemented with Endothelial Cell Growth
Kit-VEGF) (Table 1). Coacervation was induced by the addition of
Q-amylose (50 μL) to CM-amylose (50 μL) in molar charge ratios
1:1, 1:2, and 1:3 while shaking at 1400 rpm. After 7 min, terpolymer
(5 or 2 μL, 25 mg mL−1 in PEG350) was added.
Purification of Coacervates. Coacervates were purified by
centrifugation at 500g for 4 min, after which the supernatant was
carefully removed and transferred to a new Eppendorf tube. The
viscous pellet was redissolved in an equal volume of cell culture
medium.
Cell Culture. HeLa cells and RAW 264.7 macrophages were
grown as a monolayer in DMEM and supplemented with 10% (v/v)
FBS and 1% (v/v) penicillin/streptomycin in a humidified
atmosphere of 5% CO2 at 37 °C. Human umbilical vein cells
(HUVECs) were grown as a monolayer in VCBM and supplemented
with Endothelial Cell Growth Kit-VEGF in a humidified atmosphere
of 5% CO2 at 37 °C.
Cell Viability Assay. The toxicity of coacervates and its
components was evaluated using an Annexin V/7AAD apoptosis
assay. Two days prior to measuring cell viability, cells were seeded in
96-well plates and grown to 60−70% cell confluency overnight. The
following day, cells were incubated with Q-amylose, CM-amylose,
terpolymer, and coacervates. After 24 h of incubation, the cell
medium was collected and the cells were washed three times with
phosphate-buffered saline (PBS), which was also collected. Sub-
sequently, the cells were harvested using trypsin and washed three
times with PBS supplemented with EDTA (2 mM) and 2% v/v FBS,
prior to the addition of annexin binding buffer and incubation with
Annexin V and 7-AAD staining solution for 15 min in the dark at
room temperature. Samples were analyzed by flow cytometry using a
BD FACSAria III (Becton Dickinson) and FACSDiva Software
(Becton Dickinson). 7-AAD was excited at 561 nm, and emission was
recorded between 650 and 690 nm. Pacific Blue labeled Annexin V
was excited at 405 nm, and emission was recorded between 418 and
482 nm. Single cells were gated based on their forward and sideward
scatter. The percentage of viable cells was normalized to the positive
control, which was ≥75% for all samples. For each sample, >1000 cells
were recorded.
Confocal Microscopy for Visualizing Cellular Uptake. One
day prior to the addition of DyLight650-labeled terpolymer or Cy5-
labeled Q-amylose, 40.000 HeLa cells or 120.000 RAW264 cells were
seeded in an 8-well μ-ibiTreat slide (Ibidi). The next day, the medium
was replaced with fresh medium containing 1250 μg/mL terpolymer
or 250 μg/mL Q-amylose. After 4 h of incubation in a humidified
atmosphere of 5% CO2 at 37 °C, the medium was aspirated, and the
cells incubated with terpolymer were washed two times with PBS.
Cells were stained with a colocalization marker for lysosomes,
LysoTracker Green, and nuclear marker Hoechst 33342 for 20 min.
Cells were imaged in Life Cell Imaging Solution using a Leica TCS
SP5 confocal microscope equipped with an HCX PL Apo CS 63×/
1.20 UV−vis−IR water-immersion objective and PMT detector. The
pinhole was set to 1 Airy Unit. Images (1024 × 1024 pixels) were
acquired with a scan rate of 200 Hz and line-averaged three times.
DyLight650 and Cy5 were excited at 650 nm, and emission was
recorded between 670 and 780 nm. Hoechst 33342 was excited at 405
nm, and emission was recorded between 415 and 450 nm.
LysoTracker Green was excited at 500 nm, and emission was
recorded between 525 and 600 nm. Images of two independent
experiments (N = 2) were analyzed using Fiji (ImageJ).
Confocal Microscopy of Coacervates. Coacervates were
prepared using Nile Red to stain the terpolymer membrane (1% v/
v) or loaded with Cy5-labeled succinylated bovine serum albumin
(BSA) and subsequently transferred to an 18-well μ-slide (Ibidi).
Imaging of coacervates was performed using a Leica TCS SP5
Table 1. Concentrations of Amyloses Dissolved in Cell
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confocal microscope equipped with an HCX PL Apo CS 63×/1.20
UV−vis−IR water-immersion objective and PMT detector. The
pinhole was set to 1 Airy Unit. Images (1024 × 1024 pixels) were
acquired with a scan rate of 200 Hz and line-averaged six times. Nile
Red was excited at 550 nm (75% laser power), and emission was
recorded between 570 and 620 nm. Cy5 was excited at 649 nm, and
emission was recorded above 670 nm. Images were analyzed using Fiji
(ImageJ). The size and fluorescence distribution were determined
using standard ImageJ functions. The particles were selected by
thresholding the image and converting it into a binary image, using
“manual thresholding”. Overlapping images in the binary image were
separated using the “watershed” function. Subsequently, the particles
were analyzed using “particle analysis”. Particles on the edge of the
image were excluded from the analysis. A minimum of 200 particles
were analyzed per image.
Turbidity Measurements. Coacervates were prepared as
previously described with different molar charge stoichiometries.
For turbidity measurements the terpolymer was omitted. Absorption
measurements were performed on a Tecan Spark 10 M plate reader.
The turbidity of the coacervate solutions was subsequently calculated
as 100 − %T = 100 − (100 × 10−Abs500).
1H NMR Analysis. Q-amylose with degrees of substitution (DS) of
0.5 or 1 and CM-amylose with a DS of 0.4 were dissolved separately
in PBS. Coacervates were prepared as previously described with
different molar charge ratios. Coacervates were then centrifuged at
500g for 4 min, after which the supernatant was transferred to a new
Eppendorf tube and the pellet was redissolved in PBS. The samples
were subsequently freeze-dried overnight and redissolved in D2O (to
measure Q- and CM-amylose) or dimethyl sulfoxide (DMSO-d6) (to
measure terpolymer). Samples were centrifuged at 17 000g for 10 min,
and the supernatant was characterized with 1H NMR spectroscopy
(400 MHz). As a control, the same amount of polymer was dissolved
in D2O or deuterated DMSO and characterized with
1H NMR
spectroscopy. Unique compound peaks were integrated using
MestreNova and were used to calculate the ratio and concentration
of polymer in the pellet and supernatant.
■ RESULTS AND DISCUSSION
Preparation of Terpolymer-Stabilized, Coacervate-
Based Synthetic Cells in a Biologically Relevant
Medium. The first challenge in applying this synthetic cell
system in biomedical applications is their stability in a
biological environment because the phase separation of
polymers is dictated by buffer parameters, such as pH and
ionic strength.10 Coacervate microdroplets comprising Q-
amylose and CM-amylose have been reported to form at
physiological pH (7.4), with a critical salt concentration
(NaCl) of 440 mM.37 However, it is unknown whether these
particles also form in a complex and biologically relevant
environment like cell culture medium (e.g., DMEM
supplemented with serum), which is characterized by the
presence of many divalent salts (e.g., CaCl2 and MgSO4),
vitamins, polysaccharides, amino acids, and proteins (e.g.,
growth factors). To this end, Q-amylose and CM-amylose
were dissolved separately in cell culture medium and mixed for
several minutes, upon which these charged polymers phase-
separated from the original dispersion into liquid coacervate
Figure 2. Toxicity of coacervates and their components. Cell viability of HeLa cells, RAW264.7 macrophages, and human umbilical vein
endothelial cells (HUVECs) after 24 h of incubation with (A) coacervates, (B) terpolymer, (C) CM-amylose with a degree of substitution (DS) of
0.4, (D) Q-amyloseDS=1.0, and (E) Q-amyloseDS=0.5. Error bars represent the standard deviation of 2 independent experiments.
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droplets. After addition of the terpolymer PEG−PCL-g-TMC−
PGlu, discrete polydisperse particles were formed in cell
culture medium, which could then be directly used for
culturing experiments with cells (Figure 1B). Importantly,
coacervate-based synthetic cells prepared in cell culture
medium displayed stability for an extended time of at least 9
days in a humidified incubator at physiological conditions (5%
CO2 at 37 °C) while retaining their fluorescent cargo, size, and
spherical morphology (Figure S2).39 These results emphasize
the robustness of this platform for applications in a range of
biomedically relevant situations.
Toxicity Evaluation of Coacervates and Their
Components, Terpolymer and Quaternary and Carbox-
ymethyl Amyloses. Besides stability in a biologically relevant
environment, biocompatibility of complex coacervates is
crucial for establishing cellular interactions. To determine
whether coacervates or their components induced any
cytotoxicity, plasma membrane damage was assessed by
determining Annexin-V and 7-AAD positive cells. Annexin V
targets phosphatidyl serine, which is located on the intra-
cellular leaflet of the plasma membrane in healthy cells.
Because membrane asymmetry is lost during apoptosis,
phosphatidyl serine is exposed on the membrane surface
where fluorescently labeled Annexin V can bind. 7-AAD binds
DNA but is excluded from healthy cells; when cells are late
apoptotic or necrotic, 7-AAD can enter the nucleus.40 Different
cell types were included in this study: a human cancer cell line
(HeLa), a murine macrophage line (RAW264.7), and a human
umbilical vein endothelial cell line (HUVEC).
First, coacervate microdroplets were prepared in cell culture
medium and cocultivated with cells to determine their
biocompatibility. Initially, coacervates were prepared following
a previously described formulation using Q-amylose with a
degree of substitution (DS) of ≥0.8 (Q-amyloseDS≥0.8), CM-
amylose with a DS of 0.4 (CM-amyloseDS=0.4), and a charge
stoichiometry ([Q]+/[CM]−) of 3 (Figure S1).37 The DS of
Q-amylose or CM-amylose represents the number of hydroxyl
groups per amylose unit that are substituted for a quaternary
amine or a carboxymethyl group, respectively. The charge
stoichiometry represents the ratio between the number of
positive and negative charges present in the formulation. The
solvent in which the terpolymer PEG−PCL-g-TMC−PGlu was
originally dissolved was changed from DMSO to the more
biocompatible and biologically inert PEG350 to circumvent
the toxic effects reported for DMSO.41,42 For this purpose,
freeze-dried solid terpolymer was dissolved in PEG350.
Exposing cells to different concentrations of these coac-
ervate-based synthetic cells decreased cell viability by 35% for
HeLa cells and 30% for RAW264.7 macrophages when
exceeding concentrations of 100 μg mL−1 Q-amyloseDS=1.0,
60 μg mL−1 CM-amyloseDS=0.4, and 240 μg mL
−1 terpolymer
(Figure 2A).
To determine the origin of the observed coacervate toxicity,
the biocompatibilities of the separate coacervate components
were evaluated. Cells were incubated with different concen-
trations of terpolymer PEG−PCL-g-TMC−PGlu, which led to
plasma membrane damage when exceeding a concentration of
500 μg mL−1 (Figure 2B). More specifically, LC50 values
revealed that the terpolymer was most toxic for RAW264.7
cells (LC50 < 1250 μg mL
−1), followed by HUVECs (LC50 <
2500 μg mL−1) and HeLa cells (LC50 > 2500 μg mL
−1).
RAW264.7 cells are known to phagocytose anionic particles
and compounds, which might result in intracellular accumu-
lation at a high concentration. The exact mechanism of toxicity
of this group of polymers is still unknown; however,
intracellular overloading of polymeric nanoparticles has been
proposed to damage the lysosomal compartment, eventually
resulting in cell death.43 To investigate this possibility and
thereby explain the difference in toxicity between RAW264.7
cells and HeLa cells, cellular uptake studies of terpolymer
labeled with DyLight650 were performed. Indeed, RAW264.7
macrophages internalized more terpolymer inside the
lysosomes than HeLa cells, thereby supporting this hypothesis
(Figure S3).
Different terpolymer batches displayed higher toxicity for
HeLa cells (LC50 < 2500 μg mL
−1) but similar toxicity for
RAW264.7 cells (LC50 < 1250 μg mL
−1) (Figure S4). Studies
using a similar polymer (PEG−PCL-g-TMC) in nanoparticle
formulations reported comparable toxicities for different cell
lines.44,45 These data indicate that the reduced biocompati-
bility of the coacervate could be a direct consequence of
terpolymer toxicity.
Next, the two polyelectrolytes, CM-amylose and Q-amylose,
were dissolved in cell culture medium and incubated with cells.
A typical concentration for CM-amylose and Q-amylose in a
coacervate-based synthetic cell formulation is 250−500 μg
mL−1. Importantly, CM-amylose did not influence cell viability
up to 2000 μg mL−1 (Figure 2C). Moreover, Q-amylose did
not influence cell viability up to a concentration of 50 μg mL−1
(Figure 2D). However, upon increasing the concentration of
Q-amylose, cell viability sharply decreased as demonstrated by
LC50 values of Q-amylose <100 μg mL
−1 for HeLa cells and
LC50 < 250 μg mL
−1 for RAW264.7 cells and HUVECs. HeLa
cells appeared to be most prone to Q-amylose toxicity, whereas
RAW264.7 cell viability was less affected. In contrast to the
terpolymer, accumulation in the lysosomal compartments did
not contribute to this difference, as similar uptake was
observed inside RAW264.7 and HeLa cells (Figure S5).
RAW264.7 cells are thus not inclined to take up these
positively charged polymers. This is in line with observations
that phagocytotic cells like RAW264.7 cells preferably interact
with anionic particles, presumably due to their function as
bacteria scavengers, which also display a net negative charge.46
These data suggest that another mechanism is responsible for
Q-amylose toxicity. In an attempt to better understand and
overcome cytotoxicity induced by Q-amylose, the structure−
toxicity relationship of polycations was more closely examined.
Many commercially available polycations (e.g., poly-L-lysine
(PLL), poly(ethylene imine) (PEI), poly(allyl amine) (PAH),
and poly(diallyl dimethylammonium) (PDDA)) display
toxicity at comparable concentrations, limiting the scope of
these polycations for biological applications of complex
coacervates.47,32 Fortunately, the synthesis of biocompatible
polycations has also been reported.35,36 When designing such a
biocompatible polycation, understanding the mechanism of
toxicity is important but difficult to elucidate. Previous studies
describe pore formation in the phospholipid bilayers of the cell
membrane and mitochondrial disfunction as possible mecha-
nisms for cellular toxicity.48,49 Moreover, toxicity is influenced
by different properties of polycations including (i) molecular
weight, (ii) charge density and type of cationic functionality,
(iii) structure (linear vs branched), and (iv) conformational
flexibility or rigidity. The former two define the reactivity of
the polycation, whereas the latter two determine the
accessibility of the charge to the cell membrane. The toxicity
originating from Q-amylose could thus be ascribed to its
ACS Applied Materials & Interfaces www.acsami.org Research Article
https://dx.doi.org/10.1021/acsami.0c19052
ACS Appl. Mater. Interfaces 2021, 13, 7879−7889
7883
flexible structure, high molecular weight, and high charge
density. Charge density is dependent on the number of
hydroxyl groups per amylose unit that are substituted for a
quaternary amine (DS). Interaction of Q-amylose with the cell
membrane might be key to explaining the difference between
toxicity for HeLa and RAW264.7 cells. Cancer cells generally
have increased glycolytic metabolism, resulting in a more
negatively charged plasma membrane and thus stronger
interaction with cationic compounds.50 To further investigate
this hypothesis, additional studies are required in the future.
To decrease Q-amylose toxicity, a new polymer was
synthesized with a DS of 0.5 (Q-amyloseDS=0.5) that has a
lower charge density (Figure S1B and C). After exposing cells
to Q-amyloseDS=0.5, LC50 increased to >500 μg mL
−1 for HeLa
cells and HUVECs and to >1000 μg mL−1 for RAW264.7 cells
(Figure 2E). These data imply that the dense positive charge of
the original Q-amyloseDS=1.0 indeed influenced cell viability.
Overall, lowering the DS of Q-amylose represents a good
method to decrease polycation toxicity and points to Q-
amyloseDS=0.5 as the better choice regarding future biomedical
applications using coacervate-based synthetic cells.
Engineering of the Coacervate-Based Synthetic Cell
Formulation. After establishing the role in cell toxicity of the
individual components, the toxicity of the entire formulation
was evaluated and regulated. In a first attempt to improve cell
viability, the destructive interaction of positive charges with the
plasma membrane was addressed. Indeed, Q-amylose free in
solution is more toxic than Q-amylose phase-separated with
CM-amylose, as the positive charge of Q-amylose is counter-
balanced by the negatively charged CM-amylose.
However, it is possible that not all positive charge is
compensated, resulting in cell membrane damage and eventual
cell death induced by residual charge. To study this,
coacervates were prepared with the less toxic Q-amyloseDS=0.5
(Figure S6B). Interestingly, the cell viability did not improve
for both cell lines (Figure 3A and B). To address the possibility
of free Q-amylose in the dilute phase affecting cell viability, due
to excess Q-amylose in coacervate preparation, coacervates
were prepared with different charge stoichiometries. The
charge stoichiometry is one of the most significant parameters
associated with complex coacervation. Previous studies have
reported a maximum of coacervate formation for polymers of
equal length and equal charge, when the number of charges
from the polyanion is identical to the number of charges from
the polycation.10 This composition corresponds to a state of
charge neutrality with the least free polymers in solution. In the
original composition, an excess of positive charge (Q-amylose)
was added to the synthetic cells, to ensure a net positive charge
on the coacervates and consequent anchoring of the
terpolymer on the particle surface. However, maximum
coacervation, measured by the turbidity of the solution, was
observed at [Q]+/[CM]− = 1 (Figure 3C). Coacervate-based
synthetic cells were prepared with different charge stoichio-
metries varying from 1 to 3 and added to HeLa and RAW264.7
cells. Importantly the coacervates were still stabilized by the
terpolymer in these compositions (Figure S6A, C, and E).
Figure 3. Toxicity of terpolymer-stabilized, coacervate-based synthetic cells. (A, B) Cell viability after 24 h of incubation with entire synthetic cell
mixtures prepared with either Q-amyloseDS=1.0 or Q-amyloseDS=0.5 for (A) HeLa and (B) RAW264.7 cells. (C) Turbidity measurements of
coacervates with different molar charge ratios prepared in cell culture medium. (D) Cell viability after 24 h of incubation with entire synthetic cell
mixtures prepared with Q-amyloseDS=1.0 and molar charge ratios ([Q]
+/[CM]−) of 1, 2, and 3 for (D) HeLa cells and (E) RAW264.7 cells.
Concentrations on the x-axis are given in μg mL−1. Error bars represent the standard deviation of 2 independent experiments.
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Surprisingly, lowering the charge stoichiometry did not affect
HeLa cell viability and improved the cell viability of RAW264.7
cells only by maximally 15% (Figure 3D and E). This trend
was independent of the DS of Q-amylose (Figures S7 and S6B,
D, and F). These data suggest a toxicity mechanism that is
independent of the charge stoichiometry of the coacervate
formulation, either because of an excess of positive charge in
the dilute phase or by an excess of terpolymer.
In a second attempt to recover cell viability, the role of the
terpolymer in the toxicity of coacervate-based synthetic cells
was assessed. Arrangement of terpolymer PEG−PCL-g-TMC−
PGlu on the synthetic cell surface was hypothesized to
primarily expose cells to PEG44, which has been reported to be
nontoxic up to 20 mg mL−1.41 However, in previous reports, an
excess of terpolymer was added to coacervates to ensure
stabilization.37 Indeed, reducing the final terpolymer concen-
tration from 1200 to 500 μg mL−1 was revealed to be sufficient
to stabilize coacervates without obvious coalescence or size
increase (Figure 4A and B). However, decreasing the
terpolymer concentration from 1.2 to 0.5 mg mL−1
unexpectedly increased HeLa cell toxicity (Figure 4C). A
possible explanation is the diffusion of Q-amylose from the
coacervate phase to the original dispersion, as a result of lower
long-term stabilization by the terpolymer. Lowering the charge
stoichiometry and DS decreased this difference in cytotoxicity,
supporting this hypothesis (Figure S8A and C). In contrast,
lowering the terpolymer concentration returned the cell
viability of RAW264.7 macrophages to 75% (Figure 4D),
suggesting a prominent role for the terpolymer in the toxicity
of RAW264.7 cells. This was independent of the charge
stoichiometry and DS (Figure S8B and D). HeLa cells
internalize the terpolymer to a lesser extent than RAW264.7
macrophages (Figure S3), which explains why decreasing its
concentration had no positive effect on HeLa cell viability.51
All together, these data imply a different toxicity mechanism
for Hela cells and RAW 264.7 macrophages, as was also
suggested by the toxicity evaluation of the separate
compounds. A combination of free Q-amylose and terpolymer
might play a prominent role in coacervate-based synthetic cell
toxicity for HeLa cells, whereas an excess of terpolymer could
play the most prominent role in RAW264.7 toxicity.
Removal of Free Polymers by Purification. Finally, we
investigated whether the observed toxicity toward cells was an
intrinsic feature of the coacervates or a result of residual
polymer free in solution, which did not partake in the self-
assembly of the synthetic cells. To this end, coacervates were
centrifugated as previously described, after which a viscous
pellet containing the coacervates was obtained.23,39 After
careful removal of the supernatant, the pellet was redispersed
in cell culture medium (Figure 5A).
Microscopy revealed that the coacervates retained their
spherical morphology, even following this mechanical agitation
(Figure 5B). The supernatant seemed to comprise mostly large
terpolymer aggregates (Figure 5C). 1H NMR analysis was
performed to confirm the composition of supernatant and
pellet after the purification step. To this end, coacervates were
Figure 4. Terpolymer-dependent, coacervate-based synthetic cell toxicity. (A) Confocal microscopy image of coacervates prepared using 1.2 mg
mL−1 terpolymer (final concentration) or (B) 0.5 mg mL−1 terpolymer (final concentration). The terpolymer is visualized with Nile Red. Scale bar
represents 25 μm. (C, D) Cell viability after 24 h of incubation with synthetic cells for (C) HeLa cells or (D) RAW 264.7 cells. [Q]+/[CM]− = 3,
Q-amyloseDS=1.0. The final terpolymer concentration is 1.2 or 0.5 mg mL
−1. Error bars represent the standard deviation of 2 independent
experiments. Significance was assessed using the Student’s t test. Significance level is indicated by **p < 0.05.
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prepared as previously described, purified, freeze-dried, and
subsequently dissolved in NMR solvent. Integrals of unique
compound peaks were used to calculate the ratio of polymer
present in the pellet and supernatant, which was normalized to
a control (Figure S10 and Tables S1 and S2). Between 35 and
38% of terpolymer was present in the supernatant after
purification, regardless of the charge stoichiometry of Q-
amylose and CM-amylose (Figure 5D). These data suggest
that anchoring of the terpolymer on the coacervate surface is
independent of the net charge of the coacervate. This contrasts
with the previous hypothesis that a net positive charge is
required to attract the negatively charged poly(glutamic acid)
block of the terpolymer to the surface of the coacervate.
Moreover, between 27 and 55% of Q-amylose was present in
the supernatant (Figure 5E). As expected, this fraction
increased with increasing charge stoichiometry.
Following this purification step, coacervates and supernatant
were added to cells and their toxicity was determined.
Interestingly, purification of coacervates restored cell viability
to almost 70% for HeLa cells and almost 100% for RAW624.7
cells, indicating a minor role for these particles in toxicity
(Figure 5F and G). In contrast, the supernatant with
aggregated terpolymer displayed increased toxicity. The
increase and decrease of toxicity are independent of charge
stoichiometry and DS for HeLa cells (Figure S9A and C) and
RAW 264.7 cells (Figure S9B and D). These data indicate that
polymer design and coacervate purification using centrifuga-
tion are effective methods to improve the biocompatibility of
this class of protocells.
■ CONCLUSIONS
For synthetic cells to be suitable for biological applications,
they have to display excellent biocompatibility with living cells.
Figure 5. Purification of coacervate-based synthetic cells. (A) Schematic illustrating the purification process of synthetic cells. Coacervates are
centrifuged, after which the supernatant is removed, and the purified pellet is redispersed in an equal amount of cell culture medium. (B, C)
Confocal microscopy image of purified coacervates prepared using 1.2 mg mL−1 terpolymer (final concentration) (B) pellet and (C) supernatant.
The terpolymer is visualized with Nile Red. Scale bar represents 25 μm. (D, E) Fraction of compounds present in the pellet and supernatant for
(D) terpolymer and (E) Q-amylose. Fractions were calculated from 1H NMR spectra, as the ratio of peak integrals normalized to the control. Error
bars represent the standard deviation of 4 different resonances for (D) δ, 2.32−2.22 (t, 2H; CH2); δ, 2.00−1.85 (m, 2H; CH2); δ, 1.65−1.45 (m,
4H; CH2); and δ, 1.35−1.25 (m, 2H; CH2) (Figure S10A); and 2 different resonances for (E) δ, 4.50−4.35 (m, 1H; CH); and δ, 3.30−3.15 (m,
9H; CH3) (Figure S10B). (F, G) Cell viability after 24 h of incubation with DMEM, coacervates, purified coacervates, or supernatant for (F) HeLa
cells and (G) RAW264.7 cells. [Q]+/[CM]− = 3, Q-amyloseDS=1.0. The Q-amylose and terpolymer concentrations are 0.5 and 1.2 mg mL
−1,
respectively. Error bars represent the standard deviation of 2 independent experiments. Significance was assessed using the Student’s t test.
Significance levels are indicated by *p < 0.1, ***p < 0.025, or ****p < 0.01.
ACS Applied Materials & Interfaces www.acsami.org Research Article
https://dx.doi.org/10.1021/acsami.0c19052
ACS Appl. Mater. Interfaces 2021, 13, 7879−7889
7886
In this study, the impact of the structure and formulation of
our recently developed coacervate-based synthetic cell plat-
form on cell viability was thoroughly examined. Coacervates
were initially toxic when prepared using a previously reported
formulation. Consequently, the toxicities of Q-amylose, CM-
amylose, and terpolymer PEG−PCL-g-TMC−PGlu were
studied both separately and after self-assembly. CM-amylose
displayed no relevant toxicity, while Q-amylose and PEG−
PCL-g-TMC−PGlu reduced cell viability at concentrations
typical for a coacervate-based synthetic cell formulation. In an
effort to better understand and improve their biocompatibil-
ities, the coacervate formulation was optimized by varying (i)
the charge stoichiometry of Q-amylose and CM-amylose, (ii)
the degree of substitution of Q-amylose, and (iii) the
concentration of terpolymer. The cell viability could be
partially improved by synthesizing a new amylose polymer
with a reduced positive charge density. Interestingly, however,
not the coacervates but rather the free polymer was primarily
responsible for the observed toxicity. The incorporation of a
simple purification step to remove free polymers from the
coacervate solution proved to be successful in rescuing cell
viability.
To address the biomedical challenges of the future, we need
to engineer complex and adaptive micrometer-scale particles.
While the results described herein are specific to this
coacervate-based synthetic cell platform, we illustrate the
importance of taking a detailed, component-focused approach
toward investigating the viability of complex hierachically
assembled systems in close proximity with living cells.
Furthermore, these results highlight the exciting potential of
this and other modular, engineerable synthetic cell platforms
for addressing significant challenges in biomedical engineering,
such as tissue culturing and localized release of therapeutics.
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(46) Fröhlich, E. The Role of Surface Charge in Cellular Uptake and
Cytotoxicity of Medical Nanoparticles. Int. J. Nanomed. 2012, 7,
5577−5591.
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